Learn More
Medchemexpress LLC Lomitapide | 182431-12-5 | 99.6% | 693.72 | 25 MG

Supplier: Medchemexpress LLC 25MGHY14667
Lomitapide is a potent inhibitor of microsomal triglyceride-transfer protein (MTP), demonstrating an IC50 of 8 nM in vitro.
- Inhibits microsomal triglyceride-transfer protein (MTP) with an IC50 of 8 nM in vitro.
- Reduces plasma concentrations of low density lipoprotein cholesterol (LDL-C) and triglycerides.
- Indicated for the treatment of Homozygous Familial Hypercholesterolemia (HoFH).
- Metabolized via cytochrome P-450 (CYP) isoenzyme 3A4.
- Bioavailability of 7.1% and a mean half-life of 39.7 hours for the 50-mg capsule.
- Exhibits antiproliferative activity against human HepG2 cells.
- Appears as a solid, white to off-white substance.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.